Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland

[1] Sherr JL(2018)ISPAD clinical practice consensus guidelines 2018: diabetes technologies Pediatr Diabetes 19 302-325

[2] Tauschmann M(2014)Type 1 diabetes through the life span: a position statement of the American Diabetes Association Diabetes Care 37 2034-2054

[3] Battelino T(2010)Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation Health Technol Assess 14 1-323

[4] Chiang JL(2018)Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: a Meta-Analysis of Randomized Control Trials J Clin Res Pediatr Endocrinol 10 316-1662

[5] Kirkman MS(2007)Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 30 1653-412

[6] Laffel LMB(2016)Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study) Acta Diabetol 53 403-552

[7] Peters AL(2019)Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes: a population-based and propensity-matched cohort from the Swedish National Diabetes Register Diabetes Care 42 545-134

[8] Cummins E(2014)Insulin treatment in children and adolescents with diabetes Pediatric Diabetes 15 115-1424

[9] Royle P(2017)Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE) BMJ 356 j1285-A348

[10] Snaith A(2015)Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type1 diabetes: a systematic review Diabetic Med 32 1415-118

[1] Sherr JL(2018)ISPAD clinical practice consensus guidelines 2018: diabetes technologies Pediatr Diabetes 19 302-325

[2] Tauschmann M(2014)Type 1 diabetes through the life span: a position statement of the American Diabetes Association Diabetes Care 37 2034-2054

[3] Battelino T(2010)Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation Health Technol Assess 14 1-323

[4] Chiang JL(2018)Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: a Meta-Analysis of Randomized Control Trials J Clin Res Pediatr Endocrinol 10 316-1662

[5] Kirkman MS(2007)Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 30 1653-412

[6] Laffel LMB(2016)Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study) Acta Diabetol 53 403-552

[7] Peters AL(2019)Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes: a population-based and propensity-matched cohort from the Swedish National Diabetes Register Diabetes Care 42 545-134

[8] Cummins E(2014)Insulin treatment in children and adolescents with diabetes Pediatric Diabetes 15 115-1424

[9] Royle P(2017)Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE) BMJ 356 j1285-A348

[10] Snaith A(2015)Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type1 diabetes: a systematic review Diabetic Med 32 1415-118